Topics: CPI Data Is Out & Here’s What...; How Managers Can Get Better Results; $DOCU would be somewhere between... and many other

[Limex] Dear {NAME}, Some topics you might have missed. --------------------------------------------------------------- [CPI Data Is Out & Here’s What Inflation Shows]( High inflation and interest rate hikes have been two economic factors stoking fear in the stock market this year. Higher energy prices, supply chain … [Read more]( Penny Stocks [PennyStocks.com] --------------------------------------------------------------- [How Managers Can Get Better Results]( Do you own your models, or do your models own you? That's one of the driving questions in Roger Martin's new book, A New Way to Think: Your Guide To … [Read more]( Just In --------------------------------------------------------------- [$DOCU would be somewhere between $81.03 and $88.73 by 10 June 2022.]( … [Read more]( Just In --------------------------------------------------------------- [Regeneron (REGN) Stock Moves -0.64%: What You Should Know]( In the latest trading session, Regeneron (REGN) closed at $571.81, marking a -0.64% move from the previous day. This change was narrower than the S&P 500's 2.91% loss on the day. Elsewhere, the Dow lost 2.73%, while the tech-heavy Nasdaq lost 0.25%. Heading into today, shares of the biopharmaceutical company had lost 9.22% over the past month, lagging the Medical sector's gain of 2.04% and the S&P 500's gain of 0.84% in that time. Wall Street will be looking for positivity from Regeneron as it approaches its next earnings report date. The company is expected to report EPS of $9.94, down 61.47% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $2.77 billion, down 46% from the year-ago period. Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $42.38 per share and revenue of $11.57 billion. These totals would mark changes of -43.24% and -28.03%, respectively, from last year. Investors should also note any recent changes to analyst estimates for Regeneron. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.91% higher. Regeneron currently has a Zacks Rank of #3 (Hold). Digging into valuation, Regeneron currently has a Forward P/E ratio of 13.58. This valuation marks a discount compared to its industry's average Forward P/E of 20.81. We can also see that REGN currently has a PEG ratio of 1.7. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. REGN's industry had an average PEG ratio of 1.1 as of yesterday's close. The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 105, which puts it in the top 42% of all 250+ industries. The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Just Released: Zacks Top 10 Stocks for 2022 In addition to the investment ideas discussed above, would you like to know about our 10 top picks for the entirety of 2022? From inception in 2012 through 2021, the Zacks Top 10 Stocks portfolios gained an impressive +1,001.2% versus the S&P 500’s +348.7%. Now our Director of Research has combed through 4,000 companies covered by the Zacks Rank and has handpicked the best 10 tickers to buy and hold. Don’t miss your chance to get in…because the sooner you do, the more upside you stand to grab. See Stocks Now >> Click to get this free report Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report To read this article on Zacks.com click here. The … [Read more]( Just In --------------------------------------------------------------- [20% of U.S. Adults Had Major Medical Expenses Last Year. Here Are 3 Ways to Save for Healthcare]( Medical issues can pop up unexpectedly. And when they do, they can be costly. This holds true even if you have health insurance. Last year, a good … [Read more]( Just In --------------------------------------------------------------- [3 Reasons Netflix Shouldn't Buy Roku]( Rumors are swirling that Netflix (NASDAQ: NFLX) is looking to acquire Roku (NASDAQ: ROKU) after the latter closed the trading window for employees, … [Read more]( Just In --------------------------------------------------------------- [Validea Peter Lynch Strategy Daily Upgrade Report - 6/10/2022]( The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for … [Read more]( Just In --------------------------------------------------------------- [Kronos Worldwide and Yum China have been highlighted as Zacks Bull and Bear of the Day]( For Immediate Release Chicago, IL – June 10, 2022 – Zacks Equity Research shares Kronos Worldwide KRO as the Bull of the Day and Yum China YUMC asthe … [Read more]( Just In --------------------------------------------------------------- [If You Invested $1000 in MasterCard a Decade Ago, This is How Much It'd Be Worth Now]( For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help … [Read more]( Just In --------------------------------------------------------------- [Canada, in a world first, proposes health warnings on individual cigarettes]( New throughout, adds details and reaction OTTAWA, June 10 (Reuters) - Canada isproposing that written health warnings be printed on individual … [Read more]( Just In --------------------------------------------------------------- [2 Top Growth Stocks to Buy Right Now and Hold for the Long Term]( The stock market has decimated tech stocks, and many fast-growing companies are down significantly from their all-time highs. But this can provide … [Read more]( Just In --------------------------------------------------------------- [Financial Sector Update for 06/10/2022: XLF, APO, TIGR, WFC]( Financial stocks were fading in late trading Friday, with the NYSE Financial Index and the SPDR Financial Select Sector ETF (XLF) both off by about … [Read more]( Just In Follow us limex.me limex.me Warning: The links given in this email provide an automatic login to your account. For security purposes, do not share them with anyone. You received this letter because you created a Limex/WhoTrades/Try2BFunded/Score Priority/Just2Trade account. Do you want to unsubscribe from email notifications? [Edit your message settings](.